Szegvari E, Holec S, Woerman A
J Neurochem. 2025; 169(3):e70021.
PMID: 40026260
PMC: 11874209.
DOI: 10.1111/jnc.70021.
Negi N, Ayyannan S, Tripathi R
J Comput Aided Mol Des. 2025; 39(1):10.
PMID: 40021503
DOI: 10.1007/s10822-025-00588-2.
Ferreira da Silva A, Gomes A, Goncalves L, Fernandes A, Almeida A
Pharmaceutics. 2025; 17(2).
PMID: 40006510
PMC: 11858903.
DOI: 10.3390/pharmaceutics17020141.
West N, Arachchilage K, Knaack S, Hosseini M, Risgaard R, MacGregor S
bioRxiv. 2025; .
PMID: 39975363
PMC: 11839037.
DOI: 10.1101/2025.02.05.636750.
Martinez-Orozco H, Bencomo-Martinez A, Maya-Arteaga J, Rubio-De Anda P, Sanabria-Romero F, Casas Z
Int J Mol Sci. 2025; 26(3).
PMID: 39941068
PMC: 11818425.
DOI: 10.3390/ijms26031301.
Massive changes in gene expression and their cause(s) can be a unifying principle in the pathobiology of Alzheimer's disease.
Coleman P, Delvaux E, Kordower J, Boehringer A, Huseby C
Alzheimers Dement. 2025; 21(2):e14555.
PMID: 39912452
PMC: 11851168.
DOI: 10.1002/alz.14555.
Overactive Glutamatergic Basal Forebrain: Compensatory or Causal Mechanism in Cognitive Disorders.
Calderon D, Goldstein P
Anesth Analg. 2025; 140(2):350-352.
PMID: 39804597
PMC: 11731886.
DOI: 10.1213/ANE.0000000000007249.
Development of coumarin-inspired bifunctional hybrids as a new class of anti-Alzheimer's agents with potent efficacy.
Singh A, Sharma A, Singh K, Kaur K, Mohana P, Prajapati J
RSC Med Chem. 2025; .
PMID: 39790122
PMC: 11707525.
DOI: 10.1039/d4md00782d.
Pathology and Treatments of Alzheimer's Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes.
Yanai H, Adachi H, Hakoshima M, Katsuyama H
Molecules. 2025; 29(24.
PMID: 39770025
PMC: 11677283.
DOI: 10.3390/molecules29245936.
Maresin-like 1 Ameliorates Neuropathology of Alzheimer's Disease in Brains of a Transgenic Mouse Model.
Shrivastava P, Lu Y, Su S, Kobayashi Y, Zhao Y, Lien N
Biomedicines. 2025; 12(12.
PMID: 39767773
PMC: 11673747.
DOI: 10.3390/biomedicines12122865.
Essential role of sulfide oxidation in brain health and neurological disorders.
Kanemaru E, Ichinose F
Pharmacol Ther. 2024; 266:108787.
PMID: 39719173
PMC: 11806942.
DOI: 10.1016/j.pharmthera.2024.108787.
Enhanced prefrontal nicotinic signaling as evidence of active compensation in Alzheimer's disease models.
Power S, Venkatesan S, Qu S, McLaurin J, Lambe E
Transl Neurodegener. 2024; 13(1):58.
PMID: 39623428
PMC: 11613856.
DOI: 10.1186/s40035-024-00452-7.
Involvement of the VGF/BDNF axis in the neuropathology of Alzheimer's disease and its potential role in diagnosis and treatment.
Colin-Martinez E, Arias C
Rev Neurosci. 2024; .
PMID: 39566031
DOI: 10.1515/revneuro-2024-0110.
From Plaques to Pathways in Alzheimer's Disease: The Mitochondrial-Neurovascular-Metabolic Hypothesis.
Kazemeini S, Nadeem-Tariq A, Shih R, Rafanan J, Ghani N, Vida T
Int J Mol Sci. 2024; 25(21).
PMID: 39519272
PMC: 11546801.
DOI: 10.3390/ijms252111720.
Effect of Choline Alfoscerate on the Progression From Mild Cognitive Impairment to Dementia: Distributed Network Analysis of a Multicenter Korean Database Using a Common Data Model.
Pyun J, Lee I, Lee K, Kim M, Park C, Yang H
Dement Neurocogn Disord. 2024; 23(4):202-211.
PMID: 39512703
PMC: 11538851.
DOI: 10.12779/dnd.2024.23.4.202.
Heterologous expressing melittin in a probiotic yeast to evaluate its function for promoting NSC-34 regeneration.
Huang H, Hsu H, Kuo C, Wu M, Lai C, Chang G
Appl Microbiol Biotechnol. 2024; 108(1):496.
PMID: 39466458
PMC: 11519230.
DOI: 10.1007/s00253-024-13336-7.
Bibliometric and visual analysis of single-cell multiomics in neurodegenerative disease arrest studies.
Wang J, Wang S, Li Q, Liu F, Wan Y, Liang H
Front Neurol. 2024; 15:1450663.
PMID: 39440247
PMC: 11493674.
DOI: 10.3389/fneur.2024.1450663.
Isotope Encoded chemical Imaging Identifies Amyloid Plaque Age Dependent Structural Maturation, Synaptic Loss, and Increased Toxicity.
Wood J, Dulewicz M, Ge J, Stringer K, Szadziewska A, Desai S
bioRxiv. 2024; .
PMID: 39416086
PMC: 11482761.
DOI: 10.1101/2024.10.08.617019.
Regulation of Hippocamposeptal Synaptic Transmission by GABARs Is Altered in 5XFAD Mice in a Sex- and Age-Dependent Manner.
Damborsky J, Yakel J
J Mol Neurosci. 2024; 74(3):82.
PMID: 39212758
PMC: 11364565.
DOI: 10.1007/s12031-024-02260-0.
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases.
Tobin A
Nat Rev Drug Discov. 2024; 23(10):743-758.
PMID: 39143241
DOI: 10.1038/s41573-024-01007-1.
